Details

Last Funding Type

Series B

Last Funding Money Raised

$80M

Industries

Biotechnology,Genetics,Health Care,Therapeutics

Founded date

Jan 1, 2016

Number Of Employee

101 - 250

Operating Status

Active

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases. The company develops a proprietary product engine that is employed to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairment and disability. It is focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Founded in 2016, the company is based in Cambridge, Massachusetts, United States.